Zymeworks Says China's Health Regulator Accepts Biologics License Application for Cancer Therapy
Zymeworks Says China's Health Regulator Accepts Biologics License Application for Cancer Therapy
Zymeworks表示中国的健康监管机构已经接受了生物制品治疗癌症的许可申请。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册